SCHEMBL26685809

SCHEMBL26685809

Fc1cccc(C2(C(F)F)CCOC2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31568028 0.75 PKLR (0.33)
SCHEMBL31568035 0.75 TYK2 (0.42)
SCHEMBL31543237 0.73 OPRL1 (0.33)
SCHEMBL31543238 0.72 OPRL1 (0.33)
SCHEMBL26877934 0.72 OPRL1 (0.33)
SCHEMBL26685551 0.72
SCHEMBL12475153 0.70 BACE1 (0.36)
SCHEMBL1598567 0.68 MAP3K12 (0.40)
SCHEMBL26685083 0.66 PIK3CD (0.32)
SCHEMBL16416755 0.64 MAPT (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304577-A1 TYK2 INHIBITORS BIOGEN MA INC. 2025-10-02 US disclosed
EP-4522612-A1 TYK2 INHIBITORS Biogen MA Inc. (US) 2025-03-19 EP disclosed
CN-119654322-A TYK2 inhibitors 渤健马萨诸塞州股份有限公司 2025-03-18 CN disclosed
WO-2023220046-A1 TYK2 INHIBITORS BIOGEN MA INC. (US) 2023-11-16 WO disclosed
WO-2023220046-A1 TYK2 INHIBITORS BIOGEN MA INC. (US) 2023-11-16 WO disclosed